Table 6.
Clinical outcomes of high and low-volume preparations according to different schedules, n (%)
|
Outcome
|
High volume day before (n = 482)
|
High volume split-dose (n = 389)
|
P
value1
|
Low volume day before (n = 583)
|
Low volume split-dose (n = 361)
|
P
value1
|
| PDR | 149 (30.9) | 134 (34.4) | 0.277 | 145 (24.9) | 92 (25.5) | 0.833 |
| ADR | 108 (22.4) | 102 (26.2) | 0.191 | 103 (17.7) | 68 (18.8) | 0.650 |
| AADR | 30 (6.2) | 26 (6.7) | 0.783 | 20 (3.4) | 15 (4.2) | 0.567 |
| Cancer | 11 (2.3) | 8 (2.1) | 0.827 | 6 (1.0) | 9 (2.5) | 0.088 |
| SDR | 5 (1.0) | 11 (2.8) | 0.050 | 8 (1.4) | 4 (1.1) | 1.000 |
1
P value degrees of freedom = 1.
PDR: Polyp detection rate; ADR: Adenoma detection rate; AADR: Advanced adenoma detection rate; SDR: Sessile lesion detection rate.